Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
AI heavyweight Anthropic has appointed Novartis CEO Vas Narasimhan to its board of directors as the link between…
Rio Walks Away From Glencore Mega Merger on Price Impasse
Rio Tinto Group is walking away from talks to acquire Glencore Plc after the two sides failed to…
Glencore’s Congo Copper Mine Agrees Land Deal to Boost Output
Glencore Plc reached an agreement with the Democratic Republic of Congo’s state mining company over a land package…
Novartis CEO pay soars 30% to $32M in 2025
Novartis CEO Vas Narasimhan saw his realized compensation swell by 30% in 2025, reaching 24.9 million Swiss francs…
Novartis CEO eyes 2026 growth despite record patent cliff
Novartis CEO Vas Narasimhan is doubling down on a growth forecast for 2026, even as the Swiss drugmaker’s…
Roche taps Aussie oncologist to lead research—Chutes & Ladders
Welcome to this week’s Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the…
Vitol and Trafigura: Traders at the Heart of Trump’s Venezuela Oil Grab
President Donald Trump has portrayed his takeover of Venezuela’s oil sales as a victory for America, but when…
Glencore CEO Says Miners Must Do Deals After Rio Talks Fail
Glencore Plc boss Gary Nagle said the world’s top miners must get bigger in order to make their…
Ninja Picks Citigroup, Goldman, UBS for Potential $1 Billion Saudi IPO
Saudi startup Ninja has picked a roster of banks to work on a potential initial public offering in…
Swiss Leaders Seek Roche, Novartis Talks Amid US Tariffs
Switzerland’s government has reached out to local drugmakers Roche Holding AG and Novartis AG to discuss the tariff…
Swiss Ministers Meet With Roche, Novartis Amid Tariff Crisis
The Swiss government met with executives of Roche Holding AG and Novartis AG to discuss the pharmaceutical industry’s…
UBS Criticized by Senate Panel Chair Over Handling of Nazi Account Investigation
The chairman of the US Senate Judiciary Committee criticized UBS Group AG for not doing enough to investigate…